Efficacy and safety of low-dose oral minoxidil in men with androgenic alopecia

Authors

  • Federico Pastore Dr. Enrique Tornú Hospital, Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/da.v26i4.2165

Keywords:

minoxidil, androgenic alopecia

Abstract

Oral minoxidil is used alone or in combination with other therapies for the treatment of androgenic alopecia in men and women. The daily dose varies between 0.25 mg and 2.5-5 mg.
In this study, a dose of 1.25 mg / day was used as monotherapy for 24 weeks.
Thirty-two patients aged 18 to 45 years were included, of which 18 (56.2%) had never received treatment, while in 14 (43.8%) previous treatment with topical minoxidil 5% twice a day had failed. as monotherapy or with oral finasteride for at least 1.5 to 2 years.

Author Biography

Federico Pastore, Dr. Enrique Tornú Hospital, Autonomous City of Buenos Aires, Argentina

Dermatologist and Legislator. Dermatology Floor Doctor, Tornú Hospital.
Head of the Dermatology Service, Instituto César Milstein

References

I. Jha AK, Sonthalia S, Zeeshan MD, Vinay K. Efficacy and safety of very-low-dose oral minoxidil 1.25 mg in male androgenetic alopecia. J Am Acad Dermatol 2020;83:1491-1493.

II. Mckesey J, Tovar-Garza A, Pandya AG. Melasma treatment: An evidence-based review. Am J Clin Dermatol 2020;21:173-225.

Downloads

Published

2020-12-20

Issue

Vol. 26 No. 4 (2020): October-December 2020

Section

Dermatological Pearls

License

El/los autor/es tranfieren todos los derechos de autor del manuscrito arriba mencionado a Dermatología Argentina en el caso de que el trabajo sea publicado. El/los autor/es declaran que el artículo es original, que no infringe ningún derecho de propiedad intelectual u otros derechos de terceros, que no se encuentra bajo consideración de otra revista y que no ha sido previamente publicado.

 

Le solicitamos haga click aquí para imprimir, firmar y enviar por correo postal la transferencia de los derechos de autor